Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07417592

Study on the Priorities of Patients Admitted to Intensive Care

The goal of this observational study is to learn about the priorities of patients admitted to intensive care units (ICUs) who have a life-threatening condition, as well as the priorities assumed by their designated relatives and healthcare professionals (nurses, nursing assistants, ICU physicians, and general practitioners).

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Intensive Care Unit Syndrome

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Brest

Brest, 29200, France

Location contact

Thomas GARGADENNEC, MD

CONTACT

[email protected]

02 30 33 78 94 ext. +33

Thomas GARGADENNEC, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for Patient:

  • Adult Patient
  • Estimated length of stay in intensive care exceeding 72 hours
  • No objection from the patient or the designated representative, if the patient is unable to consent to participate in the study

Inclusion criteria

for Designated representative:

  • Adult Person
  • No objection to participate in the study

Inclusion criteria

for Caregiver:

  • No objection to participate in the study

Exclusion criteria

  • Patients under legal protection (guardianship, conservatorship)
  • Pregnant or breastfeeding women
  • Disagreement among the patient's relatives regarding the designated representative.

Treatment and study plan

Primary outcomes

  1. Agreement rate

    Time frame: 48 hours

    Assessment of the consistency between the priorities of patients and/or those assumed by the referring person and the priorities assumed by caregivers (resuscitation team and attending physician, if possible).

Study contacts

Contact information is provided by the study sponsor or research team.

Thomas GARGADENNEC, MD

CONTACT

[email protected]

02 30 33 78 94 ext. +33

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Acronym: PRIOREA

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Feb 18, 2026
Registry last updated
Mar 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.